KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$2.9 billion.

  • Eli Lilly's Cash from Financing Activities fell 117662.97% to -$2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 billion, marking a year-over-year decrease of 27991.87%. This contributed to the annual value of -$2.2 billion for FY2025, which is 27991.87% down from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Cash from Financing Activities is -$2.9 billion, which was down 117662.97% from $531.0 million recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Cash from Financing Activities registered a high of $3.5 billion during Q4 2023, and its lowest value of -$2.9 billion during Q4 2025.
  • For the 5-year period, Eli Lilly's Cash from Financing Activities averaged around -$351.2 million, with its median value being -$387.2 million (2021).
  • Examining YoY changes over the last 5 years, Eli Lilly's Cash from Financing Activities showed a top increase of 54320.59% in 2025 and a maximum decrease of 117662.97% in 2025.
  • Over the past 5 years, Eli Lilly's Cash from Financing Activities (Quarter) stood at -$1.5 billion in 2021, then grew by 25.23% to -$1.1 billion in 2022, then skyrocketed by 410.59% to $3.5 billion in 2023, then crashed by 106.36% to -$225.5 million in 2024, then crashed by 1176.63% to -$2.9 billion in 2025.
  • Its Cash from Financing Activities stands at -$2.9 billion for Q4 2025, versus $531.0 million for Q3 2025 and -$1.2 billion for Q2 2025.